Related Experiment Video
Updated: Feb 25, 2026

Upper-extremity Approach for Secondary Access in Transfemoral Transcatheter Aortic Valve Implantation
Published on: August 8, 2025
Impact of Pre-existing Kidney Dysfunction on Outcomes Following Transcatheter Aortic Valve Replacement
Ikechukwu A Ifedili1, Oluwaseyi Bolorunduro1, Tamunoinemi Bob-Manuel1
1Division of Cardiovascular Diseases, Department of Medicine, University of Tennessee Health Science Center/Methodist University Hospital, Mempis, Tennessee. United States.
Insights
Patients with chronic kidney disease (CKD) undergoing transcatheter aortic valve replacement (TAVR) face higher risks of mortality and complications. Early identification and management of CKD are crucial for improving TAVR outcomes.
Area of Science:
- Cardiology
- Nephrology
- Interventional Cardiology
Background:
- Pre-existing chronic kidney disease (CKD) is associated with poor outcomes in heart valve surgery.
- Evidence on CKD's impact on transcatheter aortic valve replacement (TAVR) outcomes is limited and conflicting.
Purpose of the Study:
- To systematically evaluate the effect of pre-existing CKD on TAVR outcomes.
- To compare 30-day and long-term outcomes in TAVR patients with and without CKD.
Main Methods:
- Systematic electronic search adhering to PRISMA guidelines.
- Inclusion of randomized controlled trials and observational studies.
- Comparison of outcomes based on Glomerular Filtration Rate (GFR) <60 mL/min/1.73m² versus GFR ≥60 mL/min/1.73m².
Main Results:
- Analysis of 10 studies involving 8688 patients.
- CKD patients (GFR <60) showed significantly higher 30-day mortality (OR 1.40), cardiovascular mortality (OR 1.66), stroke (OR 1.39), acute kidney injury (OR 1.42), and dialysis risk (OR 2.13).
- One-year all-cause mortality was also higher in CKD patients (OR 1.80); no differences observed in device success, bleeding, vascular complications, pacemaker needs, or paravalvular leaks.
Conclusions:
- Pre-existing CKD (GFR <60) strongly predicts worse short- and long-term outcomes post-TAVR.
- Proactive strategies are necessary to mitigate risks in TAVR patients with CKD.
Background:
Pre-existing chronic kidney disease (CKD) portends adverse outcomes following heart valve surgery. However, only limited and conflicting evidence is available on the impact of CKD on outcomes following transcatheter aortic valve replacement (TAVR). The objective of this review was to evaluate the effect of pre-existing CKD on TAVR outcomes.
Methods:
We performed a systematic electronic search using the PRISMA statement to identify all randomized controlled trials and observational studies investigating the effect of pre-existing CKD on outcomes following TAVR. 30-day and long-term outcomes were measured comparing patients with Glomerular filtration rate (GFR) ≥60 to those with GFR <60.
Results:
Ten studies were analyzed comprising of 8688 patients. Compared to patients with GFR ≥60, those with GFR < 60 had worse 30-day all cause mortality (OR 1.40, 95% CI: 1.13-1.73), cardiovascular mortality (OR 1.66, 95% CI: 1.04-2.67), strokes (OR 1.39, 95% CI: 1.05-1.85), acute kidney injury (OR 1.42, 95% CI: 1.21-1.66) and the risk for dialysis (OR 2.13, 95% CI: 1.07-4.22). There was no difference in device success (p=0.873), major or life threatening bleeds (p = 0.302), major vascular complications (p=0.525), need for pacemaker implantation (p = 0.393) or paravalvular leaks (p = 0.630). All-cause mortality at 1 year was also significantly higher in patients with GFR <60 (OR 1.80, 95% CI: 1.26-2.56).
Conclusion:
Pre-existing CKD defined as GFR <60 is a strong predictor of worse short and longterm outcomes following TAVR. Active measures should be taken to mitigate the postprocedure risk in these group of patients.
Related Concept Videos
Kidney Transplant I: Introduction
Cardiac Catheterization I: Pre-Procedure Overview
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Kidney Transplant III: Nursing Management
Acute Kidney Injury II: Pathophysiology
Kidney Transplant II: Surgical Procedure

